Results 211 to 220 of about 27,437,097 (250)
Some of the next articles are maybe not open access.

Monotherapy for hepatitis B infection: a review of treatment options

Expert Review of Anti-infective Therapy, 2015
Chronic hepatitis B (CHB) is a global health problem, causing liver failure, cirrhosis and hepatocellular carcinoma. CHB treatment aims to prevent liver-related complication. The treatment of CHB infection includes monotherapy with either interferons (IFNs) or nucleos(t)ide (NUC) analogs.
Resat, Ozaras   +6 more
openaire   +2 more sources

Entecavir: A new treatment option for chronic hepatitis B

Journal of Clinical Virology, 2006
Because of the slow kinetics of viral clearance and the spontaneous genetic variability of hepatitis B virus (HBV), antiviral therapy of chronic hepatitis B remains a clinical challenge. Despite the recent development of lamivudine, adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic HBV infection, there is still a major need
openaire   +2 more sources

Greffes [b]trachéales[/b] : options actuelles

Revue Médicale Suisse, 2011
Pavel Dulguerov   +4 more
openaire   +1 more source

Floating Clean-Tech Options for Fresh Water

World Pumps
Desalination is rapidly becoming a serious option to provide drinking water to a world struggling to come to terms with climate change and population growth. Here we look at how greener offshore alternatives are set to positively disrupt the market.
openaire   +1 more source

<b>Pricing of Options</b>

Independent Business Review
-
openaire   +1 more source

The Informational Content of High-Frequency Option Prices

Management Science, 2022
Genevieve Gauthier   +2 more
exaly  

Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi)

Journal of Acquired Immune Deficiency Syndromes, 2017
S. Phiri   +17 more
semanticscholar   +1 more source

Is Option B+ the best choice? – Authors' reply

The Lancet, 2013
Anna, Coutsoudis   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy